Watchlist Price Alert

Merrimack Pharmaceuticals... (MACK)

NASDAQ: MACK · Real-Time Price · USD

15.14

0.01 (0.07%)

At close: May 17, 2024, 7:59 PM

Merrimack Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	5.99M	19.44M	14.2M	14.04M	16.58M	20.08M	93.44M	21.52M
Short-Term Investments	12.89M	n/a	n/a	n/a	n/a	51.2M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	7.43M	10.55M	n/a
Other Long-Term Assets	4K	8K	66K	232K	1.39M	2.74M	5.26M	701K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	100K	17.47M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	102K	14.55M
Other Current Assets	309K	389K	480K	2.51M	2.11M	4.24M	1.4M	3.79M
Total Current Assets	19.18M	19.83M	14.68M	16.54M	18.69M	76.1M	95.05M	57.44M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	2.27M	6.47M	15.77M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.58M
Total Long-Term Assets	4K	8K	66K	232K	1.39M	12.44M	22.28M	24.05M
Total Assets	19.19M	19.84M	14.75M	16.78M	20.08M	88.54M	117.33M	81.48M
Account Payables	74K	188K	120K	123K	271K	1.03M	2.89M	3.38M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	36.23M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	367K	401K	442K	647K	2.5M	13.76M	16.89M	48.61M
Total Current Liabilities	441K	589K	562K	770K	2.77M	14.79M	19.78M	88.22M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	14.87M	n/a	216.86M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	56K	1.26M	3.39M
Total Long-Term Liabilities	n/a	589K	n/a	n/a	n/a	14.93M	1.26M	245.92M
Total Liabilities	441K	589K	562K	770K	2.77M	29.72M	21.04M	334.14M
Total Debt	n/a	n/a	n/a	n/a	n/a	14.87M	n/a	216.86M
Common Stock	1.34M	1.34M	1.33M	1.33M	1.33M	1.33M	1.33M	1.3M
Retained Earnings	-548.82M	-547.64M	-546.09M	-543.64M	-540.61M	-523.28M	-482.77M	-954.8M
Comprehensive Income	n/a	-0.00	-0.00	n/a	n/a	-9K	n/a	n/a
Shareholders Equity	18.75M	19.25M	14.19M	16.01M	17.31M	58.82M	96.28M	-251.12M
Total Investments	12.89M	n/a	n/a	n/a	n/a	58.63M	10.55M	n/a